Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19

BACKGROUND: Administration of Hydroxychloroquine and Azithromycin in patients with coronavirus disease 2019 (COVID-19) prolongs QTc corrected interval (QTc). The effect and safety of Lopinavir/Ritonavir in combination with these therapies have seldom been studied. OBJECTIVES: Our aim was to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Echarte-Morales, Julio, Minguito-Carazo, Carlos, del Castillo-García, Samuel, Borrego-Rodríguez, Javier, Rodríguez-Santamarta, Miguel, Sánchez-Muñoz, Enrique, Bergel-García, Rubén, González-Maniega, Clea, Prieto-González, Silvia, Menéndez-Suarez, Paula, Tundidor-Sanz, Elena, Benito-González, Tomás, Fernández-Vázquez, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698653/
https://www.ncbi.nlm.nih.gov/pubmed/33307378
http://dx.doi.org/10.1016/j.jelectrocard.2020.11.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698653/
https://www.ncbi.nlm.nih.gov/pubmed/33307378
http://dx.doi.org/10.1016/j.jelectrocard.2020.11.012

Ejemplares similares